Does METOPROLOL Cause Type v hyperlipidaemia? 7 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Type v hyperlipidaemia have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.0% of all adverse event reports for METOPROLOL.
7
Reports of Type v hyperlipidaemia with METOPROLOL
0.0%
of all METOPROLOL reports
0
Deaths
2
Hospitalizations
How Dangerous Is Type v hyperlipidaemia From METOPROLOL?
Of the 7 reports, 2 (28.6%) required hospitalization, and 1 (14.3%) were considered life-threatening.
Is Type v hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Type v hyperlipidaemia?
SACUBITRIL\VALSARTAN (25)
ASPIRIN (24)
CARVEDILOL (23)
ATORVASTATIN (22)
RAMIPRIL (22)
ALENDRONATE (21)
DAPAGLIFLOZIN (21)
ALLOPURINOL (19)
EPLERENONE (19)
EZETIMIBE (19)
Which METOPROLOL Alternatives Have Lower Type v hyperlipidaemia Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE